.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Formulary management
  • Obtain formulation and manufacturing information

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

DrugPatentWatch Database Preview

Oxytetracycline - Generic Drug Details

« Back to Dashboard

What are the generic drug sources, and freedom to operate, for oxytetracycline?

Oxytetracycline is the generic ingredient in six branded drugs marketed by Pfizer, Purepac Pharm, Impax Labs, Proter, Hikma Pharms Llc, and Ferrante, and is included in twelve NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are thirty-six drug master file entries for oxytetracycline.

Summary for Generic Name: oxytetracycline

Tradenames:6
Patents:1
Applicants:6
NDAs:12
Drug Master File Entries: see list36
Bulk Api Vendors: see list51
Clinical Trials: see list3
Patent Applications: see list11,644
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:oxytetracycline at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pfizer
TERRAMYCIN W/ POLYMYXIN
oxytetracycline hydrochloride; polymyxin b sulfate
OINTMENT;OTIC061841-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Pfizer
TERRAMYCIN
oxytetracycline hydrochloride
INJECTABLE;INJECTION060586-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Pfizer
TERRAMYCIN
oxytetracycline hydrochloride
CAPSULE;ORAL050286-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Pfizer
TERRAMYCIN
oxytetracycline
TABLET;ORAL050287-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Pfizer
TERRAMYCIN
oxytetracycline hydrochloride
CAPSULE;ORAL050286-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc